Peptides sit in a product classification that limits what can be said, shown, and implied in any ad — and getting it wrong doesn't just mean a rejected ad, it means account termination.

The client's Meta campaigns were spending money. The platform was delivering traffic. But Meta couldn't see a single conversion.

Anyone can launch ads in a restricted niche. Staying live for 73 days straight — in regulated finance on Meta — is the part most agencies can't do.

Most agencies stop at "we got you leads." In restricted verticals, that's only half the job. The other half is giving the client a way to confirm those leads are actually converting.

High-net-worth investors don't click ads on Meta. That's what every agency says. That's what this client believed before signing.

Never run an ad before in financial services. No idea where to start. No one in-house who knows how paid advertising works — and the niche is one that Meta restricts more than most.

Peptide brands on Meta face a constraint most operators don't fully grasp until it's too late: the product cannot be advertised for human use.

Most agencies won't run ads for OnlyFans . Not because the demand isn't there, but because Meta makes it structurally impossible to operate.

One campaign is a test. Eighteen months across three ad accounts in three countries is the system which generated $1.81M.

Fixed-term deposit lead gen on Meta in Germany. A niche where Business Managers most advertisers never make it past their first review cycle

They called our pricing 'extremely expensive for just Meta.' Then we turned $11K into $26K — and they couldn't stop messaging us about it.

Узнайте, как компания Zero Penny масштабировала платные кампании для бренда пептидов без перерывов, добившись 17,52 раза рентабельности инвестиций в 17,52 раза благодаря совместимым платформам и стабильной доставке продукции на Meta.